TY - JOUR
T1 - Mechanisms and implications of ADAR-mediated RNA editing in cancer
AU - Wang, Chen
AU - Zou, Jun
AU - Ma, Xiangyi
AU - Wang, Edward
AU - Peng, Guang
N1 - Publisher Copyright:
© 2017 Elsevier B.V.
PY - 2017/12/28
Y1 - 2017/12/28
N2 - Adenosine deaminases acting on RNA (ADARs) are enzymes that catalyze the conversion of adenosine (A) to inosine (I) in double-stranded RNAs. Inosine exhibits similar properties as guanosine. As a result, A-to-I editing has a great impact on edited RNAs, not only affecting the base pairing properties, but also altering codons after translation. A-to-I editing are known to mediate and diversify transcripts. However, the overall biological effect of ADARs are still largely unknown. Aberrant ADAR activity and editing dysregulation are present in a variety of cancers, including hepatocellular carcinoma, chronic myelogenous leukemia, glioblastoma and melanoma. ADAR-mediated A-to-I editing can influence uncontrolled nucleotide changes, resulting in susceptibility of cells to developmental defects and potential carcinogenicity. A deeper understanding of the biological function of ADARs may provide mechanistic insights in the development of new cancer therapy. Here, we discuss recent advances in research on ADAR in detail including the structure and function of ADARs, the biochemistry of ADAR-mediated RNA editing, and the relevance of ADAR proteins in cancer.
AB - Adenosine deaminases acting on RNA (ADARs) are enzymes that catalyze the conversion of adenosine (A) to inosine (I) in double-stranded RNAs. Inosine exhibits similar properties as guanosine. As a result, A-to-I editing has a great impact on edited RNAs, not only affecting the base pairing properties, but also altering codons after translation. A-to-I editing are known to mediate and diversify transcripts. However, the overall biological effect of ADARs are still largely unknown. Aberrant ADAR activity and editing dysregulation are present in a variety of cancers, including hepatocellular carcinoma, chronic myelogenous leukemia, glioblastoma and melanoma. ADAR-mediated A-to-I editing can influence uncontrolled nucleotide changes, resulting in susceptibility of cells to developmental defects and potential carcinogenicity. A deeper understanding of the biological function of ADARs may provide mechanistic insights in the development of new cancer therapy. Here, we discuss recent advances in research on ADAR in detail including the structure and function of ADARs, the biochemistry of ADAR-mediated RNA editing, and the relevance of ADAR proteins in cancer.
UR - http://www.scopus.com/inward/record.url?scp=85030869747&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030869747&partnerID=8YFLogxK
U2 - 10.1016/j.canlet.2017.09.036
DO - 10.1016/j.canlet.2017.09.036
M3 - Review article
C2 - 28974449
AN - SCOPUS:85030869747
SN - 0304-3835
VL - 411
SP - 27
EP - 34
JO - Cancer Letters
JF - Cancer Letters
ER -